Influence of CYP2C19 Polymorphism on Lansoprazole and Rabeprazole Maintenance Treatment of Reflux Esophagitis

被引：0
|
作者：
Koike, Tomoyuki
Iijima, Katsunori
Imatani, Akira
Shimosegawa, Tooru
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1117
引用
收藏
页码：S655 / S655
页数：1
相关论文
共 50 条
  • [1] CYP2C19 polymorphism affects the treatment effects for reflux esophagitis with lansoprazole
    Kawamura, M
    Ohara, S
    Sekine, H
    Koike, T
    Abe, Y
    Shimosegawa, T
    Yoshida, M
    Kitagawa, Y
    GASTROENTEROLOGY, 2002, 122 (04) : A195 - A195
  • [2] The therapeutic effect of lansoprazole on erosive reflux esophagitis in maintenance treatment was influenced by CYP2C19 polymorphisin
    Kawamura, M
    Ohara, S
    Sekine, H
    Koike, T
    Kitagawa, Y
    Yoshida, M
    Abe, Y
    Shimosegawa, T
    GASTROENTEROLOGY, 2003, 124 (04) : A227 - A227
  • [3] The influence of CYP2C19 polymorphism on the eradication of Helicobacter pylori:: A randomized study of lansoprazole and rabeprazole
    Jung, H. Y.
    Song, H. J.
    Choi, K. D.
    Chung, J. W.
    Kim, D. H.
    Kim, J. H.
    HELICOBACTER, 2007, 12 (04) : 429 - 429
  • [4] The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    GUT AND LIVER, 2010, 4 (02) : 201 - 206
  • [5] Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism
    Ariizumi, Ken
    Ohara, Shuichi
    Koike, Tomoyuki
    Inomata, Yoshifumi
    Iijima, Katsunori
    Sekine, Hitoshi
    Noguchi, Mitsunori
    Sugiyama, Koichi
    Eda, Yoshiki
    Kayaba, Shoichi
    Kawamura, Msashi
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (09) : 1428 - 1434
  • [6] The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism
    Kawamura, M
    Ohara, S
    Koike, T
    Iijima, K
    Suzuki, J
    Kayaba, S
    Noguchi, K
    Hamada, S
    Noguchi, M
    Shimosegawa, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) : 965 - 973
  • [7] The therapeutic effects of rabeprazole at a dose of 10mg on reflux esophagitis may not be influenced by CYP2C19 polymorphism
    Ariizumi, K
    Ohara, S
    Koike, T
    Kawamura, M
    Inomata, Y
    Kitagawa, Y
    Dairaku, N
    Iijima, K
    Imatani, A
    Kato, K
    Sekine, H
    Shimosegawa, T
    GASTROENTEROLOGY, 2004, 126 (04) : A340 - A340
  • [8] The influence of CYP2C19 on eradication of helicobacter pylori: a randomized study of lansoprazole and rabeprazole
    Lee, J. H.
    Jung, H-Y
    Choi, K-D
    Song, H-J
    Lee, G-H
    Kim, J-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A23 - A23
  • [9] Influences of CYP2C19 Polymorphism on Recurrence of Reflux Esophagitis during Proton Pump Inhibitor Maintenance Therapy
    Saitoh, Toshihito
    Otsuka, Hiroko
    Kawasaki, Takahiro
    Endo, Hitoshi
    Iga, Daijirou
    Tomimatsu, Masahiko
    Fukushima, Yasushi
    Katsube, Takao
    Ogawa, Kenji
    Otsuka, Kuniaki
    HEPATO-GASTROENTEROLOGY, 2009, 56 (91-92) : 703 - 706
  • [10] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Zalloum, Imad
    Hakooz, Nancy
    Arafat, Tawfiq
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4195 - 4200
12345